The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
暂无分享,去创建一个
S. Hammer | D. Katzenstein | M. Hughes | H. Gundacker | M. Hirsch | T. Merigan | T. Elbeik | R. Reichman | S. Rasheed | S. Fiscus | A. Japour | J. Jackson | M. Hirsch